Radiation Oncology

Gynecologic Oncology

Questions discussed in this category

What special considerations do you take when treating cancer patients with severe intellectual disabilities?

Have you been able to deliver standard of care treatment?

Despite the paucity of strong data showing benefit of chemotherapy + radiotherapy in patients with stage I-II high risk histology endometrial cancer, if you recommend treatment with both modalities, how do you determine treatment schedule?

Do you proceed with sequential, concurrent, or sandwich treatment?

4 Answers available

How would you sequence treatment of a synchronous IC1 high-grade serous ovarian cancer and cT3N1 rectal cancer?

Since there is no overlap between chemo regimens for these cancers, how would you sequence treatment?

0 Answers available

Is there still a role of brachytherapy in uterine cancer if intensity-modulated radiation therapy is available?

1 Answer available

How should molecular studies, in particular the presence of POLE or p53 mutations, be incorporated into the decision to treat an "intermediate risk" endometrial cancer patient with adjuvant therapy after hysterectomy?

Considering the ASTRO guidelines recommend against systemic therapy for patients with FIGO stage I-II endometrioid adenocarcinoma, would your recommen...

6 Answers available

Is there evidence to support or argue against intermittent fasting for cancer patients?

3 Answers available

Given patients with substantial LVSI experience a pelvic recurrence rate of ~25%, how do you counsel patients with stage IA endometrioid endometrial cancer with LVSI regarding the relative risks/benefits of EBRT versus VBT alone?

Please comment on toxicity profiles and the insufficient evidence regarding overall survival.

5 Answers available

Would you consider chemoradiation + chemotherapy as in PORTEC-3 regimen for p53 mutated stage IA endometrial cancer, though this trial did not include those with stage IA disease?

If you do not use the PORTEC-3 regimen for p53 mutated IA endometrial cancer, what specific protocol or combination of chemotherapy and radiation ther...

5 Answers available

How can oncologists be more collaborative with palliative care physicians?

How can these interactions be improved?

1 Answer available

How do you clearly communicate to parents that the main purpose of a phase I trial is to find the best dose of a new drug with the fewest side effects rather than treating the patient's cancer?

There is evidence that parents do not adequately understand the purpose of phase I pediatric cancer trials (Cousino et al., PMID 23071225).

1 Answer available

For cervical cancer intracavitary brachytherapy, do you use contrast when using CT-based planning to better visualize the ureters?

1 Answer available

How would you manage an endometrial adeno abdominal wall recurrence at the port site from prior laparoscopic surgery?

Would you offer radiation therapy? If so, what dose and fractionation would you use?

4 Answers available

How do you approach RT coverage of an abdominopelvic lymph node in the oligometastatic or oligorecurrent setting?

What factors influence whether you treat an elective nodal volume vs gross nodal volume (plus a small margin) in the setting of oligometastatic or oli...

5 Answers available

How do you manage intracranial metastases from gestational trophoblastic neoplasia?

When would you recommend SRS vs WBRT?

1 Answer available